Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing Local Mucosal Responses to Live Attenuated Influenza Vaccine in Healthy Adults

NCT07726862 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT07726862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07726862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing Local Mucosal Responses to Live Attenuated Influenza Vaccine in Healthy Adults
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 4
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
June 30, 2031
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucosal immune response to influenza vaccination